MARIANI, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 11.840
NA - Nord America 7.334
AS - Asia 3.137
SA - Sud America 179
OC - Oceania 41
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.540
Nazione #
US - Stati Uniti d'America 7.010
GB - Regno Unito 4.524
DE - Germania 1.799
IT - Italia 1.603
CN - Cina 1.586
SE - Svezia 1.225
UA - Ucraina 616
TR - Turchia 444
IN - India 439
FR - Francia 419
KR - Corea 376
RU - Federazione Russa 368
IE - Irlanda 337
CA - Canada 316
EU - Europa 250
FI - Finlandia 213
NL - Olanda 195
BE - Belgio 168
CO - Colombia 152
PL - Polonia 147
GR - Grecia 82
DK - Danimarca 80
HK - Hong Kong 78
ID - Indonesia 52
AU - Australia 37
SG - Singapore 37
VN - Vietnam 34
JP - Giappone 18
CH - Svizzera 17
IR - Iran 17
UZ - Uzbekistan 13
BR - Brasile 12
CZ - Repubblica Ceca 11
ES - Italia 11
TW - Taiwan 11
TH - Thailandia 9
CL - Cile 7
IL - Israele 7
NO - Norvegia 7
PE - Perù 7
MX - Messico 5
MY - Malesia 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
KH - Cambogia 3
PH - Filippine 3
AT - Austria 2
EG - Egitto 2
HU - Ungheria 2
MA - Marocco 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BZ - Belize 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
LK - Sri Lanka 1
LV - Lettonia 1
MT - Malta 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
Totale 22.788
Città #
Southend 4.130
Chandler 922
Frankfurt am Main 690
Seattle 589
Milan 576
Jacksonville 506
Princeton 470
Beijing 426
Ann Arbor 423
Wilmington 387
Dublin 335
Ashburn 259
Redmond 248
Nanjing 235
Mountain View 211
Woodbridge 206
Somerville 204
Dearborn 191
Toronto 189
Serra 173
Boardman 169
Brussels 160
Sakarya 160
Andover 155
Bogotá 152
Des Moines 151
Bengaluru 149
Warsaw 143
Houston 128
Fairfield 123
New York 117
Berlin 103
Ottawa 101
Jinan 92
Nanchang 89
Athens 76
Shenyang 75
Phoenix 71
Pisa 65
Hebei 60
Tianjin 53
Shanghai 51
Changsha 48
Redwood City 48
Hong Kong 47
Cambridge 45
Bitonto 38
Grafing 38
Zhengzhou 36
Hangzhou 34
Kiez 34
Auburn Hills 33
Medford 33
Norwalk 32
Jiaxing 31
Margão 30
Nürnberg 29
Lanzhou 28
Fremont 27
Kunming 27
Lowell 26
Sunnyvale 25
Verona 24
San Francisco 23
Falls Church 22
Kwai Chung 22
Palaiseau 22
Guangzhou 21
Los Angeles 21
Seoul 21
Taizhou 21
Helsinki 20
Rome 20
San Diego 20
Haikou 19
Santa Clara 18
Fuzhou 17
Hefei 16
Ningbo 16
Hamburg 14
Bühl 13
Chicago 13
Nichelino 13
Washington 13
Avola 12
Noginsk 12
Odernheim 12
Turin 12
Bologna 11
Odense 11
Changchun 10
London 10
Roxbury 10
Costa Mesa 9
Dong Ket 9
Jakarta 9
Silver Spring 9
Arese 8
San Jose 8
Sydney 8
Totale 15.071
Nome #
NOS3 Glu298Asp polymorphism is a risk factor for frontotemporal lobar degeneration 236
"Delirium Day" : A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 233
The T-786C NOS3 polymorphism in Alzheimer's disease : association and influence on gene expression 219
May migraine attack response to triptans be a predictor of the efficacy of Onabotulinum toxin-A prophylaxis? 217
GABergic neurons in the diencephalon and anterior cingulate cortex of the human brain during ageing 204
Influence of the Glu298Asp polymorphism of NOS3 on age at aonset and homocysteine levels in AD patients 203
Effectiveness of a Gait rehabilitation protocol in multiple sclerosis patients : quantification by static platform stabilometry and walking test 200
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 195
Rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells in Patients with Alzheimer’s Disease 195
Total homocysteine levels in AD patients : analysis on different onset subgroups 187
Progranulin gene mutation scanning in Alzheimer's disease and frontotemporal lobar degeneration: functional and phenotypic correlations. 184
Genetic and functional analysis of progranulin gene variants in Alzheimer's disease. 173
Is the -88 A/G polymorphism in SEL1L gene associated with Alzheimer's disease? 170
Novel exon 1 progranulin gene variant in Alzheimer’s disease 167
Progranulin gene mutation scanning in Alzheimer's disease and Frontotemporal Lobar Degeneration: fuctional and phenotypic correlations 162
Vascular risk factors do not individually effect risk of conversion of mild cognitive impairment to dementia. 162
Clinical factors associated with statins prescription in acute ischemic stroke patients : findings from the Lombardia Stroke Registry 161
Carotid endarterectomy and cognitive function in patients without cognitive impairment at baseline: a longitudinal study 160
1-40 Beta-amyloid protein fragment modulates the expression of CD44 and CD71 on the astrocytoma cell line in the presence of IL1beta and TNFalpha 160
Homocysteine and migraine 155
Negative emotions in migraineurs dreams : the increased prevalence of oneiric fear and anguish, unrelated to mood disorders 155
Weight loss predicts progression of mild cognitive impairment to Alzheimer's disease 154
Magnesium in serum from migrainous patients and healthy controls 153
Individual cerebral metabolic deficits in Alzheimer's disease and anmestic mild cognitive impairment : an FDG PET study 153
Brain natriuretic peptide as a marker of cardiac toxicity during mitoxantrone treatment in patients with multiple sclerosis 151
Frontotemporal dementia 150
Novel exon 1 progranulin gene variations in Alzheimer's disease and frontotemporal lobar degeneration 148
Low dose-topiramate-induced acute bilateral reversible glaucoma : a case report 148
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 147
Neurologia 147
Association of neuronal nitric oxide synthase C276T polymorphism with Azheimer's disease 146
Genetic and functional analysis of progranulin gene variants in patients with Alzheimer's disease 146
Nutritional status and body composition by bioelectrical impedance vector analysis : a cross sectional study in mild cognitive impairment and Alzheimer's disease 146
Mesial temporal lobe hypometabolism distinguishes amnestic from non-amnestic MCI. Automated FDG-PET image analysis 145
Plasma levels of beta amyloid (1-42) in fronto-temporal dementia 145
P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis 145
High blood pressure and other vascular risk factors in mild cognitive impairment subtypes 145
Painful peripheral neuropathies : an overview of their pathophysiology and newer approaches to treatment 144
Neuronal Nitric Oxide Synthase C276T polymorphism increases the risk for Frontotemporal Lobar Degeneration 143
Allodynia in different forms of migraine 143
Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease 143
Antinuclear antibodies in migraine patients 141
ApoE e2 and e4 influence the susceptibility for Alzheimer’s disease but not other dementias 140
A novel polymorphism in SEL1L confers susceptibility to Alzheimer's disease 136
DCUN1D1 is a risk factor for frontotemporal lobar degeneration 136
Absence of mutations in TREM-2 coding region in early onset dementia 136
I neuroni GABAergici nel diencefalo e nella corteccia cerebrale dell'uomo durante l'invecchiamento cerebrale 136
Botulinum neurotoxin - A does not spread to distant muscles after intragastric injection : a double-blind single-fiber electromyography study 136
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects : automated FDG-PET image analysis 135
Dementia with Lewy bodies with supranuclear gaze palsyc : a matter of diagnosis 134
Acute and interictal allodynia in patients with different headache forms : an Italian pilot study 133
Plasma levels of beta amyloid 1-42 in Alzheimer's disease 133
Healing Gardens: promoting health quality in a specialized intensive rehabilitation hospital 133
Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration 131
Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment 131
Absence of mutations in TREM-2 coding region in early onset dementia 131
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 131
Absence of mutations in TREM-2 coding region in patients with early onset dementia 131
Neuroanatomical, clinical and cognitive correlates of post stroke dysphagia 131
ApoE e2 decreases the susceptibility to develop Alzheimer's disease but not frontotemporal lobar degeneration, Lewy body disease or vascular dementia 129
Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain 129
Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients : an open label study 129
Moya-Moya disease in a member of a Gypsy community 128
ApoE and family history in different forms of cognitive decline 128
GRN variability contributes to sporadic frontotemporal lobar degeneration 128
Genetic and functional analysis of progranulin gene variants in Alzheimer's disease 127
CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease 126
Progranulin gene mutation scanning and expression analysis in patients with Alzheimer's disease 126
Serum folate concentrations in patients with cortical and subcortical dementias 125
APOE in differents forms of MCI 125
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 125
rs 5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells from patients with Alzheimer's disease 124
Differences in hippocampal metabolism between amnestic and non-amnestic MCI : automated FDG-PET image analysis 124
CDKN2A and CDKN2B genetic variability in Alzheimer's disease patients. 124
A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk 124
Apolipoprotein E haplotyping by denaturing high-performance liquid chromatography 123
IP-10 haplotypes and multiple sclerosis : association and correlation with clinical course 123
Evaluating two group programmes of cognitive training in mild-to-moderate AD : is there any difference between a 'global' stimulation and a 'cognitive-specific' one? 122
PGRN genetic variability in Alzheimer's disease: effect on susceptibility, age at onset and mRNS levels 122
The T-786C NOS3 polymorphism in Alzheimer's disease : association and influence on gene expression 121
The MCP-1 A-2518G polymorphism acts as protective factor for frontotemporal lobar degeneration 120
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion : late-onset psychotic clinical presentation 119
Correlation Between 123I-FP-CIT Brain SPECT and Parkinsonism in Dementia With Lewy Bodies : Caveat for Clinical Use 119
Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients 118
MCP-1 A-2518G polymorphism: effect on sysceptibility for Frontotemporel Lobar Degeneration and on cerebrospina fluid MCP-1 levels. 118
Early-onset dementia with presenilin-1 mutationand motor abnormalities in an Italian patient : a case report 117
CXCL10 haplotypes and multiple sclerosis : association and correlation with clinical course 116
Chemokine serum levels in mild cognitive impairment and Alzheimer’s disease 116
9. Congresso Sindem : Italian Association for the study of Dementia linked to the Italian Neurological Society (SIN) 116
Personality profile and allodynic migraine 115
The locus 387715 in Alzheimer’s disease 114
Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration 114
The NOS G894T (Glu298Asp) polymorphism is a risk for frontotemporal lobar degeneration 114
Novel exon 1 progranulin gene variant in Alzheimer's disease. 114
EEG changes and clinical variables in parients undergoing carotid endarterectomy 113
The MCP-1 A-2518G polymorphism acts as proctective factor for frontotemporal lobar degeneration 113
rs5848 variant influences GRN mRNA levels in patients with Alzheimer's Disease. 113
ApoE alleles distribution in different forms of Mild Cognitive Impairment 112
GRN variability contributes to sporadic frontotemporal lobar degeneration 112
CHMP5 and BAG1 are protective factors for sporadic frontotemporal lobar degeneration 112
Totale 14.192
Categoria #
all - tutte 52.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019685 0 0 0 0 0 0 0 0 232 114 144 195
2019/20202.753 329 92 151 143 222 290 257 121 435 438 211 64
2020/20212.758 129 298 292 50 268 144 177 112 314 169 669 136
2021/20222.110 190 91 42 65 141 104 271 84 268 227 147 480
2022/20233.143 413 303 260 375 387 585 58 206 379 32 99 46
2023/20241.782 49 155 98 227 897 153 79 80 44 0 0 0
Totale 24.249